Vantive Limited

Active14981842 Private limited company

Incorporated: 5 July 2023 (3 years)
Previously known as: BXT Renal Limited (until 1 September 2023)
Industry: Manufacture of basic pharmaceutical products (21100)
Manufacture of medical and dental instruments and supplies (32500)
Repair of other equipment (33190)
Directors: Cassandra Labielle Boa
Andrew John Warburton
Owned by: The Carlyle Group, Inc.
Accounts type: Full
Region: North West
Address: Wavertree Technology Park
2 Wavertree Boulevard
Liverpool
L7 9PE

Website & contact details

Website: vantive.eu

Filing status

Accounts due: 31 December 2026
Last accounts: 31 December 2024
Conf. stmt due: 18 July 2027
Last conf. stmt: 4 July 2026

Charges

Total: 1
Outstanding: 1
Part satisfied: 0
Satisfied: 0

Officers 2 active

Officer details are public data from the Companies House register.

Boa, Cassandra Labielle

Director · Appointed 10 October 2024

Irish

Born August 1989 (37)

Warburton, Andrew John

Director · Appointed 31 August 2023

British

Born September 1974 (52)

Officer history (3 former)

10 October 2024

Appointed Boa, Cassandra Labielle as Director

27 September 2024

Resigned Fitzgerald, Nicola Maria as Director

26 April 2024

Appointed Fitzgerald, Nicola Maria as Director

26 April 2024

Resigned Smialek, Michal Maciej as Director

31 August 2023

Appointed Warburton, Andrew John as Director

31 August 2023

Resigned O'Neill, Gerard Patrick as Director

5 July 2023

Appointed O'Neill, Gerard Patrick as Director

5 July 2023

Appointed Smialek, Michal Maciej as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

The Carlyle Group, Inc.

Corporate entity · Notified 31 January 2025

Owns 75–100% of shares

Holds 75–100% of voting rights

Right to appoint and remove directors

Corporation

Reg. no. 5011921

Former controllers (2)

31 January 2025

Ceased Baxter International Incorporated — Owns 75–100% of shares

8 December 2024

Ceased Baxter Healthcare Limited — Owns 75–100% of shares

What Vantive say about themselves

“Focused on vital kidney care and acute organ support therapies, digital solutions and advanced services to extend lives and expand possibilities for patients every day.”

— from vantive.eu

Filings 24

Date	Description	Made Up To
14 July 2026	Director's details changed
14 July 2026	Confirmation statement with no updates	4 July 2026
30 July 2025	Notification of a person with significant control
23 July 2025	Cessation of a person with significant control
10 July 2025	Confirmation statement with updates	4 July 2025